Toxicology of Industrial Compounds

234 PEROXISOME PROLIFERATION
KRAUPP-GRASL, B., HUBER, W., TAPER, H. and SCHULTE-HERMANN, R.,
1991, Increased susceptibility of aged rats to hepatocarcinogenesis by the
peroxisome proliferator nafenopin and the possible involvement of altered
liver foci occurring spontaneously, Cancer Research, 51, 666–71.
LAKE, B.G., 1993, Role of oxidative stress and enhanced cell replication in the
hepatocarcinogenicity of peroxisome proliferators, in Gibson, G. and Lake, B.
(Eds) Peroxisomes: Biology and Importance in Toxicology and Medicine, pp.
595– 618, London: Taylor and Francis.
LAKE, B.G. and LEWIS, D.F.V., 1993, Structure-activity relationships for
chemically induced peroxisome proliferation in rodent liver, in Gibson, G. and
Lake, B. (Eds) Peroxisomes: Biology and Importance in Toxicology and
Medicine, pp. 313– 42, London: Taylor and Francis.
LAKE, B.G., GRAY, T.J.B., PELS RIJCKEN, W.R., BEAMAND, J.A. and
GANGOLLI, S.D., 1984a, The effect of hypolipidaemic agents on peroxisomal
β-oxidation and mixed-function oxidase activities in primary cultures of rat
hepatocytes. Relationship between induction of palmitoyl-CoA oxidation and
lauric acid hydroxylation, Xenobiotica, 14, 269–76.
LAKE, B.G., GRAY, T.J.B., FOSTER, J.R., STUBBERFIELD, C.R. and
GANGOLLI, S.D., 1984b, Comparative studies on di-(2-ethylhexyl)phthalateinduced
hepatic peroxisome proliferation in the rat and hamster, Toxicology
and Applied Pharmacology, 72, 46–60.
LAKE, B.G., GRAY, T.J.B. and GANGOLLI, S.D., 1986, Hepatic effects of
phthalate esters and related compounds—in vivo and in vitro correlations,
Environmental Health Perspectives, 67, 283–90.
LAKE, B.G., LEWIS, D.F.V. and GRAY, T.J.B., 1988, Structure-activity
relationships for peroxisome proliferation, Archives of Toxicology (Supplement
12), 217–24.
LAKE, B.G., EVANS, J.G., GRAY, T.J.B., KÖRÖSI, S.A. and NORTH, C.J., 1989,
Comparative studies on nafenopin-induced hepatic peroxisome proliferation in
the rat, Syrian hamster, guinea pig and marmoset, Toxicology and Applied
Pharmacology, 99, 148–60.
LAKE, B.G., EVANS, J.G., CUNNINGHAME, M.E. and PRICE, R.J., 1993,
Comparison of the hepatic effects of nafenopin and Wy-14,643 on peroxisome
proliferation and cell replication in the rat and Syrian hamster, Environmental
Health Perspectives 101 (Supplement 5), 241–8.
LALWANI, N.D., REDDY, M.K., GHOSH, S., BARNARD, S.D., MOLELLO, J. A.
and REDDY, J.K., 1985, Induction of fatty acid β-oxidation and peroxisome
proliferation in the liver of Rhesus monkeys by DL-040, a new hypolipidemic
agent, Biochemical Pharmacology, 34, 3473–82.
LAZAROW, P.B. and DEDUVE, C., 1976, A fatty acyl-CoA oxidizing system in
rat liver peroxisomes: enhancement by clofibrate, a hypolipidaemic drug,
Proceedings of the National Academy of Sciences USA, 73, 2043–6.
LIN, L.I.-K., 1987, The use of multivariate analysis to compare peroxisome
induction data on phthalate esters in rats, Toxicology and Industrial Health, 3,
25–47.
LOCK, E.A., MITCHELL, A.M. and ELCOMBE, C.R., 1989, Biochemical
mechanisms of induction of hepatic peroxisome proliferation, Annual Reviews
of Pharma-cology and Toxicology, 29, 145–63.